Vanda Pharmaceuticals (VNDA) Assets (2016 - 2025)
Historic Assets for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q4 2025 value amounting to $488.9 million.
- Vanda Pharmaceuticals' Assets fell 2548.84% to $488.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $488.9 million, marking a year-over-year decrease of 2548.84%. This contributed to the annual value of $488.9 million for FY2025, which is 2548.84% down from last year.
- Vanda Pharmaceuticals' Assets amounted to $488.9 million in Q4 2025, which was down 2548.84% from $601.1 million recorded in Q3 2025.
- Over the past 5 years, Vanda Pharmaceuticals' Assets peaked at $656.2 million during Q4 2024, and registered a low of $488.9 million during Q4 2025.
- In the last 5 years, Vanda Pharmaceuticals' Assets had a median value of $628.3 million in 2025 and averaged $614.1 million.
- In the last 5 years, Vanda Pharmaceuticals' Assets surged by 1237.86% in 2021 and then crashed by 2548.84% in 2025.
- Over the past 5 years, Vanda Pharmaceuticals' Assets (Quarter) stood at $593.8 million in 2021, then grew by 6.81% to $634.2 million in 2022, then grew by 2.24% to $648.4 million in 2023, then grew by 1.2% to $656.2 million in 2024, then fell by 25.49% to $488.9 million in 2025.
- Its Assets stands at $488.9 million for Q4 2025, versus $601.1 million for Q3 2025 and $624.7 million for Q2 2025.